Massive lower gastrointestinal haemorrhage, successfully treated with corticosteroids, as main symptom of Schönlein-Henoch purpura.

Schönlein-Henoch purpura is a small vessel disease that affects mainly skin and kidney, although several gastrointestinal symptoms may occur including abdominal pain, intussusception, perforation or bleeding. Massive lower gastrointestinal haemorrhage is rare and even more as the main symptom of the disease. We present a case of a 2-year-old boy with Schönlein-Henoch purpura who developed a massive lower gastrointestinal bleeding requiring blood transfusion. In this patient both Schönlein-Henoch purpura and gastrointestinal haemorrhage were successfully treated with intravenous methylprednisolone, avoiding surgical intervention. Physicians need to have a high index of suspicion when evaluating these patients, even more when dermatologic signs are scarce. Glucocorticosteroid therapy may be effective when treating severe gastrointestinal symptoms.

[Noninvasive ventilation in a pediatric intensive care unit]. / Aplicación de ventilación no invasiva en una unidad de cuidados intensivos pediátricos.

OBJECTIVE: To describe our experience of noninvasive positive-pressure ventilation (NIPPV). PATIENTS AND METHODS: We performed a retrospective study of all patients who underwent NIPPV in our unit over an 18-month period. To assess the effectiveness of NIPPV, respiratory rate, heart rate, inspired oxygen, and arterial blood gases PaO2 and PaCO2 were evaluated before and 2 hours after initiating NIPPV. RESULTS: Twenty-three patients with a mean age of 36.7 months underwent a total of 24 NIPPV trials. Indications for NIPPV were: hypoxemic acute respiratory failure (14 trials), hypercapnic acute respiratory failure (four trials), and postextubation respiratory failure (six trials). Conventional ventilators were used in 10 trials and specific noninvasive ventilators were used in 14. The main interfaces used were buconasal mask in patients older than 1 year, and pharyngeal prong in infants aged less than 1 year. In all groups, significant decreases in respiratory distress, defined as a reduction in tachypnea (45 +/- 16 breaths/min pre-treatment vs. 34 +/- 12 breaths/min post-treatment; p = 0.001), and tachycardia (148 +/- 27 beats/min pre-treatment vs. 122 +/- 22 beats/min (after or post) post-treatment; p < 0.001) were observed after initiation of NIPPV. The oxygenation index PaO2/FiO2 also improved (190 +/- 109 pre-treatment vs. 260 +/- 118 post-treatment; p = 0.010). Five patients (20.8 %) required intubation and conventional mechanical ventilation after NIPPV, of which three were aged less than 6 months. CONCLUSIONS: NIPPV should be considered as a ventilatory support option in the treatment of acute respiratory failure in selected children.

[Prediction of PaO2/FiO2 ratio from SpO2/FiO2 ratio adjusted by transcutaneous CO2 measurement in critically ill children]. / Predicción del índice PaO2/FiO2 a partir del índice SpO2/FiO2 ajustado por la medición transcutánea de CO2 en niños críticamente enfermos.

OBJECTIVE: To evaluate if the inclusion of the transcutaneous CO(2) tension measurement (PtcCO(2)) can improve partial pressure of oxygen/ fraction of inspired oxygen ratio [PaO(2)/FiO(2) (P/F)] prediction from pulse oximetry saturation/FiO(2) ratio [SpO(2)/FiO(2) (S/F)]. METHODS: Retrospective analysis of blood gas data from critically ill children. PaO(2), SpO(2), FiO(2) and PtcCO(2) from 40 samples in 8 patients were analysed. A multiple linear regression model was performed to predict P/F ratio from S/F ratio and PtcCO(2). Using the equation obtained, S/F ratio values were calculated for P/F ratios of 200 and 300 and different levels of PtcCO2. Receiver Operator Characteristic (ROC) curves were made to analyse the diagnostic values of P/F ratio (200 and 300). RESULTS: The linear regression model was: P/F=37.277+(1.072×S/F) - (1.567×PtcCO2); P<.0001; R(2)=0.469. Using the equation, for a PtcCO(2) value of 40 mmHg, P/F ratios of 200 and 300 corresponded to S/F ratios of 295.1 and 426.5, respectively. Computed P/F ratio less than 256.7 had 84.6% sensitivity and 85.2% specificity for the diagnosis of P/F ratio less than 200. Computed P/F ratio less than 297.6 had 89.7% sensitivity and 82% specificity for the diagnosis of P/F ratio less than 300. CONCLUSION: PtcCO(2) has a significant influence on the prediction of P/F ratio from S/F ratio. Prospective studies with more patients are needed to validate these results.

[Use of peripherally inserted multilumen catheters as an alternative to central venous access]. / Utilización de catéteres multilumen de acceso periférico como alternativa a las vías centrales.

BACKGROUND: In the last decade alternatives to central venous lines in critically ill children have been developed. Multilumen catheters have classically been used through central venous access but there are no reports on their use as peripherally inserted central lines. PATIENTS AND METHODS: We performed a retrospective study of patients admitted to the pediatric intensive care unit in the previous 3 years who underwent catheterization with peripherally inserted central venous lines. The catheters were four French, double-lumen and 30-cm long. RESULTS: Twenty-two catheters were used in 22 children (mean age: 8.3 years; range 1.7-13.8). The catheters remained in place for a mean of 7.2 days. Ninety percent of the catheters were placed in antecubital veins. The catheters were used to administer antibiotics (59 %), other drugs (81 %), total parenteral nutrition (50 %) and blood (9 %). Central venous pressure monitoring was performed in eight patients. Complications were found in five patients (22 %): three cases of phlebitis, one catheter occlusion and one infection at the site of insertion. No significant differences were found in the complication rate between peripherally inserted catheters and 298 central venous catheters inserted in our unit in the same time period. CONCLUSIONS: Peripherally inserted multilumen catheters may be an alternative in the management of critically-ill pediatric patients.